Top 10 Performing Stocks To Invest In 2018

The Q4 2016 earnings report for small capsupercomputer stock Cray Inc (NASDAQ: CRAY) is scheduled forafter the market closes onWednesday (February 8th). Back in 2012, Cray Inc was inour SmallCap Network Elite Opportunity (SCN EO) portfolioasa potentially goodlow risk longer-term play as shares were trading at the $12 level and eventually hit $40+ per share before coming back down to earth last year.

A look at Cray Incs technical chart shows the falloff that occurred for most of last year:

A long term performance chart shows Cray Incstill and by far outperforming other supercomputer players likelarge caps International Business Machines Corp (NYSE: IBM) andHewlett-Packard Company (NYSE: HPQ) plus small cap Silicon Graphics International Corp (NASDAQ: SGI):

Top 10 Performing Stocks To Invest In 2018: Plains All American Pipeline L.P.(PAA)

Advisors’ Opinion:

  • [By ]

    The market has pummeled master limited partnerships (MLPs) over the past few years due to the impact the oil market downturn had on their operations and business model. Among the hardest-hit have been oil pipeline MLP Plains All American Pipeline (NYSE:PAA) and gas pipeline giant Energy Transfer Partners (NYSE:ETP), both of which have lost more than half their value over the last three years. That persistent slump comes even though their turnaround strategies are beginning to gain steam. While these companies still have some work to do before they’re back on solid ground, both could deliver significant returns as they complete their plans and the oil market continues rebounding over the next few years. That upside potential makes them compelling options for investors with a higher tolerance for risk.

  • [By Dustin Parrett]

    We think Plains All American Pipeline L.P. (NYSE: PAA) is one of the best oil stocks to buy this year. In fact, we see a scenario where PAA stock could jump 20% in 2017.

  • [By Matthew DiLallo]

    One of the largest projects is the Saddlehorn Pipeline, which Magellan is building with Plains All American Pipeline (NYSE:PAA) and Anadarko Petroleum (NYSE:APC). Both Plains All American Pipeline and Magellan own 40% of the project, which puts their total investment at $230 million apiece. They expect the project to be fully operational early next year, which is noteworthy given its robust first-year economics. Magellan estimates that it will earn eight times EBITDA on the capital deployed, or roughly $28.8 million in annual EBITDA apiece for Magellan and Plains All American Pipeline on their investment.

  • [By Dustin Parrett]

    Plains All American Pipeline (NYSE: PAA) controls 4 million barrels of crude oil and natural gas a day.

    And with higher oil prices and fewer restrictions leading to more drilling, PAA’s pipelines will be in demand in 2017.

Top 10 Performing Stocks To Invest In 2018: CLARCOR Inc.(CLC)

Advisors’ Opinion:

  • [By Monica Gerson]

    CLARCOR Inc. (NYSE: CLC) is estimated to post its quarterly earnings at $0.40 per share on revenue of $310.87 million.

    Tilly’s Inc (NYSE: TLYS) is expected to post its quarterly earnings at $0.11 per share on revenue of $155.43 million.

Top 10 Performing Stocks To Invest In 2018: Constellation Brands Inc(STZ)

Advisors’ Opinion:

  • [By Chris Lange]

    And Constellation Brands Inc. (NYSE: STZ) will report its fiscal third-quarter results before Friday’s opening bell. The consensus estimates are EPS of $1.88 and revenue of $1.87 billion. Shares closed most recently at $223.30, in a 52-week range of $144.00 to $229.41. The consensus price target is $237.58.

  • [By Asit Sharma]

    After four years of wildly successful expansion in its beer business, supplemented by lucrative wine portfolio additions,Constellation Brands, Inc. (NYSE:STZ) might seem to be nearing a revenue plateau.But rather than fizzling out from sheer exhaustion, the Victor, New York-based alcoholic beverage giant is likely to continue to exhibit outperformance in the near to medium term, for two simple reasons that we’ll dive into below.

  • [By WWW.THESTREET.COM]

    Is it time to crown a new king of beers? After speaking with Constellation Brands (STZ) CEO on Thursday night’s show, Cramer said it was time to take a fresh look at the beer sector to see if a reshuffling is in order.

Top 10 Performing Stocks To Invest In 2018: Brown Forman Corporation(BF.B)

Advisors’ Opinion:

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday Brown-Forman Corp. (NYSE: BF.B) which rose nearly 7% to $66.01. The stocks 52-week range is $64.29 to $67.98. Volume was over just over 1 million compared to its average volume of 0.7 million.

Top 10 Performing Stocks To Invest In 2018: (LVMUY)

Advisors’ Opinion:

  • [By ]

    French luxury house LVMH SE (LVMUY) stock surged 3.55% in Paris, changing hands at 278.8 after it reported better-than-expected first quarter sales. Organic revenues rose by 13% in the first three months of the year, driven by its fashion and leather goods division.

  • [By SEEKINGALPHA.COM]

    (Incidentally, the operating structure and history of growth through smart acquisitions and management is a reminiscent story behind the rise of Bernard Arnault and The Arnault Family Group, which is the majority controlling shareholder in LVMH Mo毛t Hennessy Louis Vuitton S.E. (OTCPK:LVMUY) and Christian Dior SE in the ultra-luxury goods industry.)

  • [By ]

    Two years ago, I discussed LVMH (OTCPK:LVMUY) (OTCPK:LVMHF) in another article here on Seeking Alpha. Although I wasnt too impressed with the companys free cash flow yield, I did agree this company deserved a premium valuation. And on top of that, I was expecting its strong growth results to continue in the years ahead. Were now two years later, and LVMH has delivered on every front. Unfortunately the market caught up on that as well, and LVMHs share price has doubled in just two years. And although the LVMH results justify a good performance of the share price, I do think LVMH is getting a little pricey.

Top 10 Performing Stocks To Invest In 2018: Microchip Technology Incorporated(MCHP)

Advisors’ Opinion:

  • [By Lee Jackson]

    This company is a huge Internet of Things benefactor. Microchip Technology Inc. (NASDAQ: MCHP) is a leading provider of microcontroller, mixed-signal, analog and flash-IP solutions, providing low-risk product development, lower total system cost and faster time to market for thousands of diverse customer applications worldwide.

  • [By ]

    Though concerns have been raised that the analog and MCU markets are at risk of seeing an inventory correction (they haven’t had a major one in a while), given signs of excessive ordering and stretched lead times, TI and STMicro’s numbers suggest conditions remain good for now. That’s particularly true in industrial and auto markets where trends such as factory automation, ADAS adoption and electric/hybrid car sales are boosting chip demand. Several other analog/MCU firms, including Microchip (MCHP) , ON Semiconductor (ON) , Maxim Integrated (MXIM) and NXP Semiconductors (NXPI) , will be reporting soon.

  • [By Ben Levisohn]

    My colleague Tiernan Rey at Barron’s Tech Trader Daily quoted B. Rileys Craig Ellis in a post today, who called the selloff yesterday an unusually attractive entry opportunity forApplied Materials andMicrochip Technology (MCHP) buyers.

  • [By ]

    Crutcher added that TI’s own chip manufacturing teams have been pushing equipment suppliers to make their machinery smarter. “We want it to tell us sooner if there’s an issue with the [chip] wafer that’s going through that machine,” he said as an example. Fellow analog chip and microcontroller (MCU) suppliers such as Analog Devices (ADI) and Microchip (MCHP) also have strong industrial exposure.

Top 10 Performing Stocks To Invest In 2018: Electro Scientific Industries, Inc.(ESIO)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Elite Opportunity Pro (EOP) portfolio newsletter has suggestedsmall cap laser-based manufacturing solutions stockElectro Scientific Industries (NASDAQ: ESIO). According tothe Company itself: Its integrated solutions allow industrial designers and process engineers to control the power of laser light to transform materials in ways that differentiate their consumer electronics, wearable devices, semiconductor circuits and high-precision components for market advantage. The Company’s laser-based manufacturing solutions feature the micro-machining industry’s highest precision and speed, and target the lowest total cost of ownership.To put that more into layman terms: Electro Scientific Industries systems enable precise engineering and testing of micron to submicron features in semiconductors, LEDs, multi-layer ceramic capacitors (MLCCs), printed circuit boards (PCBs), flex circuits and other high-value components – all of which are vital to our economy.

Top 10 Performing Stocks To Invest In 2018: NCI, Inc.(NCIT)

Advisors’ Opinion:

  • [By Elizabeth Balboa]

    Information technology company NCI Inc (NASDAQ: NCIT) reported its $283 million sale to H.I.G. Capital Management for $20 per share in cash.

    9. Allied World Assurance

    The insurance firms of Allied World Assurance Company Hldgs Ltd (NYSE: AWH) and Fairfax Financial extended the offering period for purchase of outstanding Allied World shares from June 30 to July 5.

Top 10 Performing Stocks To Invest In 2018: Hibbett Sports Inc.(HIBB)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, cyclical consumer goods & services shares fell 0.03 percent. Meanwhile, top losers in the sector included Francesca's Holdings Corp (NASDAQ: FRAN), down 5 percent, and Hibbett Sports, Inc. (NASDAQ: HIBB) down 5 percent.

  • [By Mark Balson]

    Hibbett Sports (HIBB) financial results have come out with better than expected earnings for the fiscal 2017 first quarter.

    Revenue for the first quarter was $282.09 million which is 4.6% higher to year on year data. This is below expectations for analysts who were projected revenue to be at $285.15 million. Compare to 0.9% decline in net sales last year this year store sales increased 1.1%. 

  • [By Paul Ausick]

    Hibbett Sports Inc. (NASDAQ: HIBB) posted a new 52-week low of $13.30 on Monday, down about 33% from Friday’s closing price of $19.70. Volume totaled around 6.7 million shares, about 13 times the daily average of around 550,000. The company issued a profit warning this morning and a late e-commerce launch.

Top 10 Performing Stocks To Invest In 2018: Sanofi(SNY)

Advisors’ Opinion:

  • [By Max Byerly]

    COPYRIGHT VIOLATION NOTICE: “Sanofi (SNY) Stock Rating Reaffirmed by Deutsche Bank” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this story on another domain, it was illegally stolen and reposted in violation of United States & international copyright & trademark legislation. The original version of this story can be read at https://www.tickerreport.com/banking-finance/3361890/sanofi-sny-stock-rating-reaffirmed-by-deutsche-bank.html.

  • [By ]

    While vaccines are not thought to be as effective this year, the severity of the season could drive higher volume for drug makers. Experts have said the AstraZeneca (NYSE: AZN) vaccine FluMist may not be effective against this year’s strain of flu and are instead recommending the Sanofi (NYSE: SNY) FluZone vaccine. GlaxoSmithKline (NYSE: GSK) has recently been approved for use of its FluLaval vaccine in children as young as six months.

  • [By Stephen Mack]

    JNJ has recently made substantial investments in its pharmaceuticals pipeline. Most notably, in January the company beat Sanofi SA (NYSE: SNY) to buy a stake in Swiss drug company Actelion. The pairing is a perfect match, as it bulks up Johnson & Johnson’s pipeline, and gives Actelion the reach of a global powerhouse.

  • [By Brian Feroldi]

    Shares of Flexion Therapeutics (NASDAQ:FLXN) rose by more than 33% at$26.28 in Thursday trading, in response to rumors that a takeover bid from Sanofi (NYSE:SNY) is looming.

  • [By Sean Williams]

    MannKind has just one Food and Drug Administration-approved therapy, an inhalable type 1 and type 2 diabetes drug known as Afrezza. On paper Afrezza looked like a winner. It was fast-acting, it metabolized through the body more quickly than traditional insulin, and it was exceptionally convenient since there were no needles involved. The company also wound up licensing the drug out to Sanofi (NYSE:SNY) in 2014, netting much needed upfront capital and help on the expenses front.